We collated a total of 159 tumor samples bearing BRAF mutations, 133 with NRAS mutations, 303 with KRAS mutations, and 96 with EGFR mutations from the URMC NGS database from June 2020 to July 2021. This evidence concerns the gene EGFR and neoplasm.